Description
KLOW is a four-component research formulation containing GHK-Cu 50 mg, BPC-157 10 mg, TB-500 10 mg and KPV 10 mg, supplied at a total content of 80 mg. The formulation is intended for laboratory investigation of combined peptide systems, comparative pathway research and multi-component analytical studies.
Blend breakdown: GHK-Cu 50 mg | BPC-157 10 mg | TB-500 10 mg | KPV 10 mg | Total 80 mg
Product specification
| Product | KLOW | Quantity | 80 mg total |
| Form | Lyophilised material | SKU | KLOW80 |
| Purity | Refer to batch-specific COA | Identity | Refer to batch-specific COA |
| Batch documentation | Available | Research use | Laboratory and in-vitro research only |
Research use only. Supplied exclusively for laboratory, analytical and in-vitro research. Not for human or animal consumption, clinical use, diagnosis, treatment or administration. Refer to the batch-specific COA for available identity and purity data.
